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Cardiovascular diseaseAbstract Background: Electrocardiographic (ECG) abnormalities are indepen-
dently associated with poor outcomes in the general population. Their prevalence
and determinants were assessed in the understudied African American population
with type 2 diabetes.
Methods: Standard 12-lead ECGs were digitally recorded in 635 unrelated African
American-Diabetes Heart Study (AA-DHS) participants, automatically processed at a
central lab, read, and coded using standard Minnesota ECG Classification. Age- and
sex-specific prevalence rates of ECG abnormalities were calculated and logistic
regression models were fitted to examine cross-sectional associations between
participant characteristics and ECG abnormalities.
Results: Participants were 56% women with a mean age of 56 years; 60% had at
least one minor or major ECG abnormality [23% P1 major (or major plus minor),
and 37% P1 minor (with no major)]. Men had a higher prevalence of P1 minor or
major ECG abnormality (66.1% men vs. 55.6% women, p = 0.0089). In univariatedicine,
290 M.B. Sellers et al.analysis, age, past history of cardiovascular disease, diabetes duration, systolic
blood pressure, sex and statin use were associated with the presence of any (major
or minor) ECG abnormalities. In a multivariate model including variables, female sex
(OR [95% CI] 0.79 [0.67, 0.93]), statin use (0.79 [0.67, 0.93]) and diabetes duration
(1.03 [1.0, 1.05]) remained statistically significant.
Conclusions: Nearly three out of five African Americans with diabetes had at least
one ECG abnormality. Female sex and statin use were significantly associated with
lower odds of any ECG abnormality and diabetes duration was significantly
associated with higher odds of any ECG abnormality in the multivariable model.
ª 2014 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Associations between minor and major electrocar-
diographic (ECG) abnormalities and incident car-
diovascular disease (CVD) are widely observed
[1–6]. These associations persist after adjustment
for traditional CVD risk factors suggesting they are
independent. A higher prevalence of ECG abnor-
malities has been reported in African Americans
(AAs) relative to European Americans [7,8] – a
finding in accordance with higher CVD rates in the
general AA population. Patients with diabetes are
at a significantly increased risk of CVD events,
and diabetes is widely accepted as a coronary
artery disease risk equivalent [9–11].
Few studies have assessed the prevalence and
determinants of ECG abnormalities in AAs with
type 2 diabetes (T2D). It is currently recom-
mended by the American Heart Association/Amer-
ican College of Cardiology Foundation (AHA/ACCF)
guidelines to obtain ECGs for those with diabetes
[12]. However, it remains unclear how best to
use the results of the ECG to improve patient
care. Information regarding the prevalence of
ECG abnormalities in the high risk AA population
with T2D could help guide efforts to develop risk
stratification tools to identify those who may ben-
efit from closer follow-up and aggressive risk fac-
tor management. There are potential subsets of
patients with diabetes with high risk features that
may be further elucidated by the ECG, a non-inva-
sive and low-cost screening modality. The preva-
lence and associations of ECG abnormalities
were examined in AAs with T2D enrolled in the
African American-Diabetes Heart Study (AA-DHS),
one of the most extensively phenotyped African
ancestry cohorts for CVD and related risk factors
in populations with diabetes.2. Methods
2.1. Study population
The study sample included 635 consecutive unre-
lated, self-reported AAs with T2D recruited in the
parent Diabetes Heart Study (DHS) and subsequent
AA-DHS. In the DHS, siblings concordant for T2D
were recruited from internal medicine clinics and
community advertising [4]. One member of each
AA sib-pair was included and T2D was diagnosed
after the age of 34 years in the absence of histori-
cal evidence of ketoacidosis. An additional 555
unrelated AAs were subsequently enrolled in the
AA-DHS using the same diagnostic criteria, except
that T2D was diagnosed after the age of 30 years.
Inclusion criteria in both studies allowed individu-
als with prior myocardial infarction, angina, con-
gestive heart failure, transient ischemic attack,
and stroke, but excluded those with previously
diagnosed advanced nephropathy (estimated glo-
merular filtration rate <60 ml/min/1.73 m2 or
end-stage renal disease). Although not excluding
participants with prevalent cardiovascular disease
may lead to overestimation of ECG abnormalities,
it is well established that the diabetic population
are at high risk of CVD and excluding those with
CVD will risk the representative nature of this sam-
ple. Identical examinations were conducted in the
Clinical Research Unit of the Wake Forest School
of Medicine in DHS and AA-DHS, including inter-
views for medical history, current medications
and health behaviors, measurements of body size,
resting blood pressure, 12-lead ECG, fasting blood
draw, and spot urine collection. These studies were
approved by the Institutional Review Board at the
Wake Forest University School of Medicine, and
all participants provided written informed consent.
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A resting 12-lead ECG was obtained from all partic-
ipants using a GE MAC 1200 electrocardiograph (GE,
Milwaukee, Wisconsin). The digitally collected ECG
tracings were transmitted via phone line to be cen-
trally read and coded at the Epidemiological Cardi-
ology Research Center (EPICARE), Wake Forest
School of Medicine (Winston-Salem, NC). All ECGs
were initially checked for quality before being
automatically processed using the GE Marquette
12-SL version 2001 software (GE, Milwaukee, Wis-
consin). The Minnesota coding system was used to
classify ECG tracings as having a major or minor
abnormality [13]. Participants with only minor
ECG abnormalities were classified as having ‘‘any
minor abnormalities’’, and participants with major
ECG abnormalities with or without coexisting minor
ECG abnormalities were classified as having ‘‘any
major ECG abnormalities’’. Major ECG abnormali-
ties included: major ventricular conduction defect;
definite myocardial infarction (defined as the pres-
ence of major Q wave abnormalities); possible
myocardial infarction (defined as the presence of
minor Q/-QS wave plus major ST/-T abnormali-
ties); major isolated-ST/-T abnormalities; left ven-
tricular hypertrophy; major atrioventricularTable 1 Baseline characteristics stratified by the presence o
With ECG* abnormality
Number 382
Age (years) 56.8 (9.7)
Female (%) 65.38%
Body mass index (kg/m2) 34.5 (8.5)
Smoking (%)
Current 25.13%
Ever 37.70%
Never 37.17%
Age at diabetes (years) 46.0 (10.5)
Diabetes duration (years) 11.2 (9.0)
Hemoglobin A1C (%) 8.3 (2.0)
Total cholesterol (mg/dL) 180.7 (46.8)
LDL-cholesterol (mg/dL) 107.5 (37.8)
HDL-cholesterol (mg/dL) 47.4 (13.5)
Triglycerides (mg/dL) 131.4 (140.2)
Dyslipidemia (%) 89.79%
Hypertension (%) 84.76%
Systolic blood pressure (mmHg) 135.1 (20.2)
Diastolic blood pressure (mmHg) 77.7 (11.6)
History of CVD (%) 5.5%
Use of diabetes medications
Insulin (%) 44.24%
Oral (%) 74.35%
Statin use (%) 52.49%
* Values expressed by N (%) or mean (SD); CVD – cardiovascular di
 p values for the presence of ECG abnormalities versus absence oconduction abnormalities; major QT prolongation
(QTP 116%), pacemaker, and other major arrhyth-
mias. Minor ECG abnormalities included: minor iso-
lated Q/-QS waves; minor isolated ST/-T
abnormalities; high R waves; ST segment elevation;
incomplete (left and right) bundle branch block;
minor QT prolongation (QTiP 112%); short PR
interval; left axis deviation; right axis deviation;
frequent ventricular premature beats; and other
minor arrhythmias.
2.3. Statistical analysis
Baseline characteristics were described for the
total cohort, and the prevalence of ECG abnormal-
ities (minor, major, and any minor or major) was
tabulated in all participants and stratified by the
presence or absence of ECG abnormalities. The
prevalence rates of ECG abnormalities were com-
pared between each baseline covariate (Table 1)
and between men and women (Table 2) using chi
square tests for categorical variables and the Wil-
coxon two-sample test for continuous outcomes,
as appropriate. Logistic regression models were
run to test the association between ECG abnormal-
ities (major, minor, and major/minor) adjusted for
different sets of covariates, considered in af ECG abnormalities.
Without ECG* abnormality Combined* sample p-Value
208 590
54.4 (9.2) 56.0 (9.5) <0.01
52.09% 56.78% <0.01
36.0(8.2) 35.0(8.5) 0.02
0.48
23.08% 24.72%
34.62% 36.85%
42.31% 38.43%
45.4 (9.4) 45.8 (10.0) 0.53
8.8 (5.8) 10.3 (8.1) 0.04
8.0 (2.0) 8.2 (2.0) 0.08
182.8 (43.6) 181.7 (45.2) 0.45
109.6(37.2) 108.7(37.3) 0.45
48.4 (13.7) 47.7 (13.5) 0.41
125.9 (102.8) 130.0 (125.0) 0.76
91.83% 90.51% 0.47
78.85% 82.65% 0.09
131.1 (17.4) 133.6 (19.3) 0.03
77.5 (11.3) 77.5 (11.4) 0.96
0.96% 3.9% <0.01
32.21% 40.00% <0.01
83.17% 77.46% 0.02
42.31% 48.90% 0.02
sease.
f ECG abnormalities.
Table 2 Prevalence of ECG abnormalities stratified by sex.
Description Men
% (N) of
abnormalities
Women
% (N) of
abnormalities
Combined
% (N) of
abnormalities
p-Value
Any major or minor ECG abnormality (%) 66.1% 55.6% 60.0% <0.01
Minor ECG abnormalities 59.90% 50.80% 54.8% 0.03
Minor isolated Q,QS waves 9.8% (27) 7.0% (25) 8.2% (52) 0.37
Minor isolated ST,T abnormalities 22.7% (63) 25.4% (91) 24.3% (154) 0.71
High R waves 15.6% (44) 16.8% (60) 16.4% (104) 0.88
ST segment elevation, anterolateral site 1.8% (5) 1.4% (5) 1.6% (10) 0.85
ST segment elevation, posterior site 1.4% (4) 0.6% (2) 0.9% (6) 0.51
ST segment elevation, anterior site 3.6% (10) 2.5% (9) 3.0% (19) 0.71
Incomplete right bundle branch block 0.7% (2) 1.4% (5) 1.1% (7) 0.86
Incomplete left bundle branch block 16.3% (45) 5.3% (19) 10.1% (64) <0.01
Minor QT prolongation 2.5% (7) 2.8% (10) 2.7% (17) 0.55
Short PR 0% (0) 0.3% (1) 0.2% (1) 1.00
Left axis deviation 8.3% (23) 2.8% (10) 5.2% (33) <0.01
Right axis deviation 0% (0) 0% (0) 0% (0) 0.75
Frequent ventricular premature beats 3.3% (9) 3.1% (11) 3.2% (20) 1.00
Other minor abnormalities 12.6% (35) 10.4% (34) 10.9% (69) 0.25
Major ECG abnormalities 26.40% 20.50% 23.00% 0.12
Complete left bundle branch block 0% (0) 0.6% (2) 0.3% (2) 0.65
Complete right bundle branch block 1.4% (4) 2.0% (7) 1.7% (11) 0.96
Nonspecific intraventricular block 1.4% (4) 0.6% (2) 1.0% (6) 0.58
Complete/intermittent RBBB w/left anterior hemiblock 0% (0) 0.3% (1) 0.18% (1) 1.00
Major Q wave abnormalities [old MI] 7.2% (20) 3.9% (14) 5.4% (34) 0.16
Minor Q/QS waves with ST/T abnorm. (possible old MI) 2.5% (7) 2.0% (7) 2.2% (14) 0.85
Major isolated ST-T abnormalities 12.3% (34) 11.5% (41) 11.8% (75) 0.89
Left ventricular hypertrophy (with strain pattern) 4.0% (11) 5.6% (20) 4.9% (31) 0.65
Atrial fibrillation 1.1% (3) 0.3% (1) 0.6% (4) 0.32
Major QT Prolongation 1.1% (3) 1.1% (4) 1.26% (7) 0.42
Pacemaker 0% (0) 0.6% (2) 0.3% (2) 0.61
292 M.B. Sellers et al.sequential fashion. Models were constructed as fol-
lows: univariate model, multivariable model
adjusted for covariates that were statistically sig-
nificant in the univariate model. Statistical signifi-
cance was defined as p < 0.05. Analysis was
performed using SAS version 9.1 (SAS institute,
Cary, NC).Fig. 1 Prevalence of any major and major or mino3. Results
The study sample included 635 unrelated AAs with
T2D having a mean ± SD age of 56 ± 9.5 years, 56%
(n = 358) were women. Characteristics of the study
population are detailed in Table 1 stratified by the
presence or absence of ECG abnormalities. Partic-r ECG abnormalities by genders and age groups.
Table 3 Associations between cardiovascular disease risk factors and ECG abnormalities.
Any ECG abnormality Major ECG abnormalities Minor ECG abnormalities
Univariate
OR (95% CI)
Multivariable*
OR (95% CI)
Univariate
OR (95% CI)
Multivariable*
OR (95% CI)
Univariate
OR (95% CI)
Multivariable*
OR (95% CI)
Age (per year) 1.02 (1.01, 1.04) 1.01 (0.99, 1.03) 1.03 (1.00, 1.05) 1.01 (0.99, 1.04) 1.01 (0.99, 1.02)
Female sex 0.80 (0.68, 0.94) 0.79 (0.67, 0.93) 0.84 (0.68, 1.04) 0.89 (0.74, 1.06)
Body mass index (kg/m2) 0.98 (0.96, 1.00) 0.99 (0.96, 1.01) 0.99 (0.97, 1.01)
HDL cholesterol (per 1 mg.dl) 0.99 (0.98, 1.01) 0.99 (0.97, 1.00) 1.00 (0.99, 1.01)
LDL cholesterol (per 1 mg.dl) 1.00 (0.99, 1.00) 1.00 (0.99, 1.00) 1.00 (0.99, 1.00)
Triglycerides (per 1 mg.dl) 1.00 (0.99, 1.00) 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
Total cholesterol (per 1 mg.dl) 0.99 (0.99, 1.00) 0.99 (0.99, 1.00) 0.99 (0.99, 1.00)
Statin (use vs. no use) 0.79 (0.67, 0.93) 0.83 (0.70, 0.99) 0.74 (0.60, 0.92) 0.84 (0.67, 1.06) 0.78 (0.65, 0.93) 0.80 (0.67, 0.95)
Systolic BP (per 1 mmHg) 1.01 (1.00, 1.02) 1.01 (1.0, 1.02) 1.02 (1.01, 1.03) 1.01 (1.00, 1.03) 1.00 (0.99, 1.01)
Hypertension 0.84 (0.68, 1.04) 0.69 (0.50, 0.95) 0.76 (0.53, 1.08) 0.96 (0.76, 1.20)
**CV disease 0.59 (0.36, 0.97) 0.63 (0.36, 1.09) 0.37 (0.22, 0.63) 0.36 (0.20, 0.65) 0.71 (0.40, 1.28)
Hgb HbA1C 1.06 (0.97, 1.14) 1.06 (0.96, 1.17) 1.05 (0.96, 1.15)
Insulin use 0.90 (0.65, 1.23) 1.01 (0.52, 1.97) 0.57 (0.28, 1.14)
Duration DM (per year) 1.04 (1.01, 1.06) 1.03 (1.0, 1.05) 1.03 (1.00, 1.05) 1.03 (1.01, 1.05) 1.03 (1.00, 1.05)
Smoking (vs. current smoker) 0.92 (0.74, 1.14) 0.91 (0.68, 1.23) 0.85 (0.66, 1.09)
* Multivariate analysis including factors significant in the univariate model, unadjusted for multiple comparisons.
** CV Disease = history of coronary artery bypass surgery or carotid endarterectomy.
 Insulin = diabetes off treatment versus insulin therapy.
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294 M.B. Sellers et al.ipants with ECG abnormalities, relative to those
without, were more likely to be older, female,
having lower body mass indices, longer diabetes
durations, higher systolic blood pressures, history
of cardiovascular disease defined as prior coronary
artery bypass surgery or carotid endarterectomy,
and were more often taking insulin and statin med-
ications (Table 1).
Approximately 60% (N = 381) of participants had
P1 minor or major ECG abnormality. Major ECG
abnormalities were present in 23% and minor ECG
abnormalities (with no major abnormality) in
54.8% of participants. Table 2 presents prevalent
ECG abnormalities stratified by sex. The most com-
mon finding was minor isolated ST-T abnormalities
seen in 24.3% of the participants, followed by high
R waves (16.4%), major isolated ST-T abnormalities
(11.8%), other minor arrhythmias (10.9%), and
incomplete LBBB (10.1%). Relative to women,
men were more likely to have an incomplete LBBB
(p 6 0.0001) and a left axis deviation (p < 0.0001).
In sex-stratified analysis, major ECG abnormalities
had a statistically significant p-value for trend
(p = 0.0069) in men for every 10 year increase in
age from 30 to >70 years. In women, major or
minor abnormalities had a statistically significant
p for trend (p = 0.025) for 10-year incremental
increase in age (Fig. 1).
Results of the logistic regression analysis exam-
ining associations between ECG abnormalities, sex
and other CVD risk factors are shown in Table 3.
In the univariate analysis, age (odds ratio [OR]
1.02, [95% Confidence Interval] 1.01, 1.04), pres-
ence of cardiovascular disease defined as prior cor-
onary artery bypass graft surgery or carotid
endarterectomy (OR 0.59 [0.36, 0.97]), diabetes
duration (OR 1.04 [1.01, 1.06]), systolic blood pres-
sure (OR 1.01 [1.0, 1.02]), sex (OR 0.80 [0.68,
0.94]) and statin use (OR 0.79 [0.67–0.93]) were
associated with major or minor ECG abnormalities.
In the univariate analysis of the association with
major ECG abnormalities, similar results were seen
with age, presence of cardiovascular disease,
systolic blood pressure and statin use; however,
diabetes duration and sex were not statistically sig-
nificant. In the univariate analysis of the associa-
tion with minor ECG abnormalities, only diabetes
duration and statin use were statistically significant
(OR 1.03 and 0.78, respectively). In the multivari-
able analysis of any ECG abnormality, including
variables that were statistically significant in each
univariate analysis, diabetes duration, sex, and
statin use remained statistically significant with
ORs (95% CI) 1.03 (1.00, 1.05), 0.79 (0.67, 0.93),
and 0.83 (0.70, 0.99), respectively. In the multivar-iable analysis of only minor ECG abnormalities,
diabetes duration OR 1.03 (1.00, 1.05) and statin
use OR 0.80 (0.67, 0.95) were statistically signifi-
cant. Finally, multivariable analysis of major ECG
abnormalities revealed that a history of coronary
artery bypass surgery or carotid endarterectomy
(OR 0.36 [0.20, 0.65]) and systolic blood pressure
(OR 1.01 [1.00, 1.03]) were statistically significant.
4. Discussion
Existing reports evaluating the prevalence and sig-
nificance of ECG abnormalities has predominantly
been performed in middle-aged men of European
ancestry. The Atherosclerosis Risk in Communities
(ARIC) [8], Charleston Heart Study [6], Evans
County Study [14] and Coronary Artery Risk Devel-
opment in Young Adults (CARDIA) [7] studies illus-
trate the impact of race/ethnicity on ECG
abnormalities. However, these studies included a
minor subset of AAs with diabetes, and in some
studies diabetes was an exclusion criterion. There-
fore, the AA-DHS is uniquely situated to provide
insights regarding the prevalence of ECG abnormal-
ities in AAs with T2D. A remarkably high prevalence
of ECG abnormalities was detected in the AA-DHS
cohort; 23% of subjects had major abnormalities
and 54.8% had minor abnormalities. In comparison,
AAs in CARDIA had 10.2% major abnormalities and
17.7% minor abnormalities. In ARIC, AAs had
5.5% and 33% major and minor abnormalities,
respectively.
Several results from the AA-DHS parallel existing
data in AAs. In CARDIA, high R wave voltage (23.3%
in AA men, 11% in AA women), followed by any
minor ST-T abnormalities (15.2% and 12.7%,
respectively), and incomplete LBBB (17.4% and
4.2%, respectively) were among the most common
ECG abnormalities seen in AAs [7]. In ARIC, high
amplitude R waves (19.1% in AA men and 11% in
AA women), minor T wave abnormalities (10.7%
and 8.6%, respectively) and ST segment elevation
(14.6% and 0.2%, respectively) were among the
most common findings. High amplitude R waves
were also found to be more prevalent in the Evans
County Study [14]. It appears that the relative
distributions of individual ECG abnormalities from
AA-DHS are in accordance with those reported in
ARIC, CARDIA, and Evans County; however, their
overall prevalence was far higher. The high preva-
lence of ECG abnormalities in AA-DHS may partially
explain the reported poor CVD outcomes in AAs and
in patients with diabetes.
The prevalence and distribution of ECG
abnormalities in this study that included African
ECG Abnormalities in African Americans 295Americans are comparable to the estimates
reported from Africans living in Africa [15–19]. It
is important, however, to notice that African
Americans are different from Africans still living
in Africa. Despite the common ancestry, the wes-
tern lifestyle has changed the characteristics and
disease patterns dramatically in individuals with
African ancestry. Also, the methods of defining
ECG abnormalities between those in this study
(using Standard Minnesota code at a central ECG
core lab) and these studies trigger the need to be
careful in making direct comparisons. This calls
for a comparative study between blacks living in
different places (Africans living in Africa, African
Americans, African Caribbean, African Europeans,
etc.) using a similar methodology. This study was
also less informed about the variations in normal
ECGs between blacks and whites [19]. So, a white
comparison group may have been useful for inter-
pretation of the ECG abnormalities in this study,
which was not possible in this study and is one of
the limitations.
Associations between ECG abnormalities and
CVD events are well established in the general
and patient-based populations [1–3,5,6,20,21].
The remarkably high prevalence of ECG abnormal-
ities in AAs with T2D will require examination of
the risk of CVD-associated events with ECG abnor-
malities. At this stage, follow-up outcomes data
in the AA-DHS are lacking and the association
between ECG abnormalities and CVD cannot be
examined. Additional study limitations inherent
to the cross-sectional design include potential
residual confounding in the logistic regression mod-
els. In addition, ECGs were obtained at one time
point. Some ECG criteria may be dynamic in nature
and could arguably be more significant if multiple
ECGs were obtained at different time points.
Finally, by design, AA-DHS participants with an
estimated glomerular filtration rate <60 ml/min/
1.73 m2 or end-stage renal disease were excluded.
This may impact the generalizability of the results
if applied to the spectrum of diabetics with renal
disease. Therefore, a population without advanced
CKD was needed and hence recruitment did not
consider those with advanced CKD.
In conclusion, the prevalence and associations of
ECG abnormalities in AAs with T2D enrolled in the
AA-DHS were evaluated. ECG abnormalities were
highly prevalent in this population; nearly 60%
had at least one minor or major ECG abnormality
and 23% had major ECG abnormalities. Female
sex and statin use were significantly associated
with lower odds of any ECG abnormality, and dia-
betes duration was significantly associated withhigher odds of any ECG abnormality in the multivar-
iable model. Additional studies are warranted to
determine whether these ECG abnormalities are
independently associated with CVD outcomes in
the high risk and understudied AA population with
T2D. If these ECG abnormalities aid in the
identification of an exceptionally high risk
subgroup of patients with diabetes, earlier use of
specific cardiovascular interventions may be
warranted targeting primary prevention.Funding
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